Nkgen Biotech Inc (NKGN)

$0.26 +0.07 (35.91%)
Market Cap 8.60M
Revenue (ttm) 0.00
Net Income (ttm) -82.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.10
Volume 1,562,500
Avg Vol 4,676,562
Day's Range N/A - N/A
Shares Out 44.95M
Stochastic %K 0%
Beta 0.45
Analysts Strong Buy
Price Target N/A

Company Profile

NKGen Biotech, Inc., a clinical-stage biotechnology company, develops and commercializes cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells in the United States. The company develops SNK01, an autologous NK cell therapy candidate in Phase I/IIa trial for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease; and SNK02, which consists of an allogenic NK cell therapy that has completed Phase 1 trial and a HE...

Industry: Biotechnology
Sector: Healthcare
Phone: 949 396 6830
Address:
3001 Daimler Street, Santa Ana, United States
RupertDCat
RupertDCat Mar. 21 at 10:41 PM
$NKGN https://www.linkedin.com/posts/paul-y-song-md-7664147_adpd2026-ugcPost-7441123320705474560-zPpl?utm_medium=ios_app&rcm=ACoAAAm5LksBlME8Y5PuvN1rjw1zbzyfmTRN8Pc&utm_source=social_share_send&utm_campaign=messages
0 · Reply
RupertDCat
RupertDCat Mar. 20 at 12:46 AM
$NKGN https://www.linkedin.com/posts/paul-y-song-md-7664147_adpd2026-ugcPost-7440537902868172800-2G4N?utm_medium=ios_app&rcm=ACoAAAm5LksBlME8Y5PuvN1rjw1zbzyfmTRN8Pc&utm_source=social_share_send&utm_campaign=messages
0 · Reply
RupertDCat
RupertDCat Mar. 20 at 12:35 AM
$NKGN https://www.linkedin.com/posts/paul-y-song-md-7664147_adpd2026-activity-7440536106170826752-Q-be?utm_source=share&utm_medium=member_ios&rcm=ACoAAAm5LksBlME8Y5PuvN1rjw1zbzyfmTRN8Pc
0 · Reply
dmb1879
dmb1879 Mar. 18 at 6:34 PM
$NKGN wonder what is up with these mini spikes...
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Mar. 18 at 1:14 AM
$NKGN show the world PHASE 2 !!!! Don’t be shy !!!!!
0 · Reply
MTBolz
MTBolz Mar. 18 at 1:09 AM
$NKGN let’s go!
0 · Reply
AshbyFH
AshbyFH Mar. 17 at 7:29 PM
$NKGN
0 · Reply
whereisthebull50
whereisthebull50 Mar. 17 at 2:39 PM
$NKGN tired of their phase 1 data. How long they will stick to phase 1. Come on, show us some update on phase 2 a.
0 · Reply
RupertDCat
RupertDCat Mar. 16 at 3:01 PM
$NKGN https://www.linkedin.com/posts/paul-y-song-md-7664147_proud-to-announce-the-opening-of-our-newest-ugcPost-7439298962844504064-6E85?utm_medium=ios_app&rcm=ACoAAAm5LksBlME8Y5PuvN1rjw1zbzyfmTRN8Pc&utm_source=social_share_send&utm_campaign=messages
1 · Reply
Picklerinthekitchen
Picklerinthekitchen Mar. 13 at 6:49 PM
$NKGN well fun while it lasted at .20 !
0 · Reply
Latest News on NKGN
No data available.
RupertDCat
RupertDCat Mar. 21 at 10:41 PM
$NKGN https://www.linkedin.com/posts/paul-y-song-md-7664147_adpd2026-ugcPost-7441123320705474560-zPpl?utm_medium=ios_app&rcm=ACoAAAm5LksBlME8Y5PuvN1rjw1zbzyfmTRN8Pc&utm_source=social_share_send&utm_campaign=messages
0 · Reply
RupertDCat
RupertDCat Mar. 20 at 12:46 AM
$NKGN https://www.linkedin.com/posts/paul-y-song-md-7664147_adpd2026-ugcPost-7440537902868172800-2G4N?utm_medium=ios_app&rcm=ACoAAAm5LksBlME8Y5PuvN1rjw1zbzyfmTRN8Pc&utm_source=social_share_send&utm_campaign=messages
0 · Reply
RupertDCat
RupertDCat Mar. 20 at 12:35 AM
$NKGN https://www.linkedin.com/posts/paul-y-song-md-7664147_adpd2026-activity-7440536106170826752-Q-be?utm_source=share&utm_medium=member_ios&rcm=ACoAAAm5LksBlME8Y5PuvN1rjw1zbzyfmTRN8Pc
0 · Reply
dmb1879
dmb1879 Mar. 18 at 6:34 PM
$NKGN wonder what is up with these mini spikes...
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Mar. 18 at 1:14 AM
$NKGN show the world PHASE 2 !!!! Don’t be shy !!!!!
0 · Reply
MTBolz
MTBolz Mar. 18 at 1:09 AM
$NKGN let’s go!
0 · Reply
AshbyFH
AshbyFH Mar. 17 at 7:29 PM
$NKGN
0 · Reply
whereisthebull50
whereisthebull50 Mar. 17 at 2:39 PM
$NKGN tired of their phase 1 data. How long they will stick to phase 1. Come on, show us some update on phase 2 a.
0 · Reply
RupertDCat
RupertDCat Mar. 16 at 3:01 PM
$NKGN https://www.linkedin.com/posts/paul-y-song-md-7664147_proud-to-announce-the-opening-of-our-newest-ugcPost-7439298962844504064-6E85?utm_medium=ios_app&rcm=ACoAAAm5LksBlME8Y5PuvN1rjw1zbzyfmTRN8Pc&utm_source=social_share_send&utm_campaign=messages
1 · Reply
Picklerinthekitchen
Picklerinthekitchen Mar. 13 at 6:49 PM
$NKGN well fun while it lasted at .20 !
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Mar. 11 at 1:32 AM
$NKGN
0 · Reply
RupertDCat
RupertDCat Mar. 10 at 2:05 PM
$NKGN https://www.stocktitan.net/news/NKGN/nk-gen-biotech-to-present-integrated-phase-1-clinical-and-biomarker-2vh2ir2k3p2n.html
0 · Reply
MTBolz
MTBolz Mar. 8 at 7:26 AM
$NKGN
0 · Reply
BCINU
BCINU Mar. 5 at 10:37 PM
$NKGN bullish it has a great future
0 · Reply
dmb1879
dmb1879 Mar. 5 at 8:03 PM
$NKGN
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Feb. 20 at 12:32 AM
$NKGN
0 · Reply
Pedro1979
Pedro1979 Feb. 17 at 9:29 PM
$NKGN I wish you and your team all the best and I believe in NKGen. Greetings from Austria. Peter
0 · Reply
dmb1879
dmb1879 Feb. 17 at 9:27 PM
$NKGN
0 · Reply
BCINU
BCINU Feb. 17 at 7:31 PM
$NKGN Paul Song announced: Paul Y. Song, MD 5d As my mom worked for nearly 25 years as the educational director of the Newark, NJ Head Start program, it is especially meaningful for me to be back in Newark at University Hospital (Rutgers Health) where we will soon open our first clinical trial site in the NY/NJ metropolitan region. As this center cares for an ethnically diverse disadvantaged community, I am grateful to have this opportunity to offer our #troculeucel NK cell therapy for neurodegenerative disease to further their mission and to work with Dr. Jack Tsao and his amazing staff.
1 · Reply
RupertDCat
RupertDCat Feb. 15 at 2:24 AM
$NKGN https://www.linkedin.com/posts/paul-y-song-md-7664147_troculeucel-activity-7427762509262159872-g_kn?utm_source=share&utm_medium=member_ios&rcm=ACoAAAm5LksBlME8Y5PuvN1rjw1zbzyfmTRN8Pc
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Feb. 14 at 2:44 AM
$NKGN
0 · Reply
whereisthebull50
whereisthebull50 Feb. 13 at 3:17 PM
$NKGN Now it’s very hard to believe anything This company says. They can’t keep their own words. Enrollment supposed to be completed by last year June. Trading on otcqx or nasdaq supposed to be started by Dec last year, Phase 2a initial result supposed to be by Dec last year. Now in a recent interview CEO said results in the middle of this year. Why do they need to do this ? Hope it’s not an another version of SAVA.
1 · Reply